Tsai Huang-Wen, Hsieh Fu-Chien, Chang Chih-Chun, Su Ming-Jang, Chu Fang-Yeh, Chen Kuo-Hsin, Jeng Kuo-Shyang, Chen Yun
Department of Surgery, Far Eastern Memorial Hospital, Taipei City, Taiwan E-mail :
Asian Pac J Cancer Prev. 2015;16(17):8009-13. doi: 10.7314/apjcp.2015.16.17.8009.
Orthotopic organ transplantation, a treatment option for irreversible organ dysfunction according to organ failure, severe damaged organ or malignancy in situ, was usually accompanied with massive blood loss thus transfusion was required. We aimed to evaluate the adverse impact of blood transfusion on solid organ transplantation.
From January, 2009 to December, 2014, patients who received orthotopic organ transplantation at Far Eastern Memorial Hospital medical center were enrolled. Clinical data regarding anemia status and red blood cell (RBC) transfusion before, during and after operation, as well as patient outcomes were collected for further univariate analysis.
A total of 105 patients who underwent orthotopic transplantation, including liver, kidney and small intestine were registered. The mean hemoglobin (Hb) level upon admission and before operation were 11.6 ± 1.8 g/dL and 11.7 ± 1.7 g/dL, respectively; and the nadir Hb level post operation and the final Hb level before discharge were 8.3 ± 1.6 g/dL and 10.2 ± 1.6 g/dL, respectively. The median units (interquartile range) of RBC transfusion in pre-operative, peri-operative and post-operative periods were 0 (0-0), 2 (0-12), and 2 (0-6) units, respectively. Furthermore, the median (interquartile range) length of hospital stay (LHS) from admission to discharge and from operation to discharge were 28 (17-44) and 24 (16-37) days, respectively. Both peri-operative and post-operative RBC transfusion were associated with longer LHS from admission to discharge and from operation to discharge. Furthermore, it increased the risk of post-operative septicemia. While peri-operative RBC transfusion elevated the risk of acute graft rejection in patients who received orthotopic transplantation.
Worse outcome could be anticipated in those who had received massive RBC transfusion in transplantation operation. Hence, peri-operative RBC transfusion should be avoided as much as possible.
原位器官移植是针对因器官衰竭、严重器官损伤或原位恶性肿瘤导致的不可逆器官功能障碍的一种治疗选择,通常会伴随大量失血,因此需要输血。我们旨在评估输血对实体器官移植的不良影响。
纳入2009年1月至2014年12月在远东纪念医院医疗中心接受原位器官移植的患者。收集术前、术中和术后关于贫血状况和红细胞(RBC)输血的临床数据以及患者结局,进行进一步的单因素分析。
共登记了105例行原位移植的患者,包括肝、肾和小肠移植。入院时和术前的平均血红蛋白(Hb)水平分别为11.6±1.8 g/dL和11.7±1.7 g/dL;术后Hb最低点水平和出院前的最终Hb水平分别为8.3±1.6 g/dL和10.2±1.6 g/dL。术前、围手术期和术后红细胞输血的中位数(四分位间距)单位分别为0(0 - 0)、2(0 - 12)和2(0 - 6)单位。此外,从入院到出院以及从手术到出院的住院时间(LHS)中位数(四分位间距)分别为28(17 - 44)天和24(16 - 37)天。围手术期和术后红细胞输血均与从入院到出院以及从手术到出院的较长住院时间相关。此外,它增加了术后败血症的风险。而围手术期红细胞输血增加了接受原位移植患者急性移植物排斥的风险。
预计在移植手术中接受大量红细胞输血的患者预后较差。因此,应尽可能避免围手术期红细胞输血。